CEA as a prognostic index in colorectal cancer
Keywords:
CEA, Colorectal cancer, RecurrenceAbstract
INTRODUCTION: The carcinoembryonic antigen, CEA, is the tumor marker most used in colorectal patients, principally during follow up after radical surgery. High serum CEA level before surgery is often associated with worse prognosis, in some studies. OBJECTIVE: The purpose of this study was to evaluate the preoperative carcinoembryonic antigen levels (CEA) and the frequency of recurrence. MATERIAL AND METHODS: Eighty-three patients with colorectal cancer at Dukes stages A, B or C were evaluated retrospectively. The patients' follow up was at least two years or to death. CEA was detemined in serum by enzyme immunoassay (Sorin Biomedica), normal value 0-5ng/mI. RESULTS: Disease recurrence was observed in 32 patients (38.5%), 13 Dukes B and 19 Dukes C. Seventy five per cent of the patients with CEA higher than 10ng/ml relapsed and 80% of the patients without recurrence had normal CEA. Disease recurrence in patients with preoperative elevated CEA occurred during the first year of follow up in 56% of the patients. CONCLUSION: Although the tumor stage is today the most valuable prognostic variable in colorectal cancer, the preoperative CEA value can provide some additional information in the prognosis of the patient.
Downloads
References
Gold P.; Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med. 1965;121: 439-62.
Barone C; Astone A; Cassano A; et al. Advanced colon cancer: Staging and prognosis by CEA Test. Oncology 1990; 47: 128-132.
Groslin R; Steele G JR; MacIntyre J; et al. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann. Surg. 1980; 192: 747-751.
Tsuchiya, A; Ando Y; Kikushi, Y; et al. Reappraisal of preoperative carcinoembryonic antigen levels as a prognostic factor in resectable colorectal cancer. J. Med. Sci., 1994; 40: 9-17.
Wanebo H.J.; Rao B.;Pinsky CM; et al. Preoperative carcinoembryonic antigen level as prognostic indicador in colorectal cancer. N. Engl. J. Med. 1978; 299: 448-451.
Carpelan-Holmstrom M.; Haglund C.H.; Roberts P. J.; Differences in serum tumor markers between colon and rectal cancer. Dis Colon Rectum 1996; 39:799-805.
Chu DZJ.; Erickson CA.; Russell P.; Thompson C.; Lang NP.; Broadwater RJ.; Westbrook KC; Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Arch Surg.1991; 126:314-316.
Steele, G.Jr.; Ellenberg, S.; Ramming, K et al. (GITSG). Carcinoembryonic antigen monitoring among patients in multinstitutional adjuvant G.I. therapy protocols. Ann. Surg. 1982; 196:162-9.
Wang, J.Y.; Tang, R. & Chiang, M. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis. Colon. Rectum;1994; 37: 272-7.
Tate H. Plasma CEA in the post-surgical monitoring of colorectal carcinoma. Br. J. Cancer. 1982; 46: 323-330.
McCall, JL.; Black, RB; Rich, CA., et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis. Colon Rectum 1994; 37: 875-881.
Carpelan-Holmstrom M., Haglund C., Lundin J.; Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer. Eur. Journal Cancer 1996; 32A: 1156-1161.
Northover J. The use of prognostic markers in surgery for colorectal cancer. 1995: 31A:1207-1209.
